Quantum dots-βcyclodextrin-histidine labeled human adipose stem cells-laden chitosan hydrogel for bone tissue...

Area of Science:

• Biomaterials Science
• Stem Cell Biology
• Nanotechnology

Background:

• Mesenchymal stem cells (MSCs) are vital for tissue engineering due to their differentiation potential.
• Tracking MSC fate is crucial for understanding their function in tissue regeneration.
• Developing effective cell-labeling and differentiation-inducing agents is essential for regenerative medicine.

Purpose of the Study:

• To develop a dual-purpose nano-carrier for labeling human adipose stem cells (hASCs) and inducing osteogenic differentiation.
• To evaluate the traceability of labeled hASCs within 2D and 3D culture environments.
• To assess the potential of the nano-carrier for applications in cell therapy and tissue engineering.

Main Methods:

• Histidine-conjugated β-cyclodextrin attached to quantum dots (QDs) formed the QD-βCD-His nano-carrier.
• Human adipose stem cells (hASCs) were labeled with QD-βCD-His.
• The labeled cells' traceability was monitored in 2D cultures and 3D chitosan hydrogel scaffolds.
• Dexamethasone (Dex) was loaded into the nano-carrier to create QD-βCD-His@Dex for osteoinduction.

Main Results:

• QD-βCD-His successfully labeled hASCs, enabling their traceability in both 2D and 3D scaffolds.
• The QD-βCD-His@Dex nano-carrier demonstrated the ability to induce bone differentiation in the labeled hASCs.
• The nano-carrier exhibited good biocompatibility and cell-penetrating properties.

Conclusions:

• QD-βCD-His@Dex is a promising dual-functional nano-carrier for stem cell labeling and osteogenic induction.
• This technology holds potential for advancing cell-based therapies and tissue engineering strategies.
• The developed nano-carrier facilitates cell tracking and controlled differentiation for regenerative medicine applications.